**Study on Ibezapolstat for Treating Recurrent C. difficile Infections** This study tests a medicine called ibezapolstat for people who keep getting sick with a germ named C. difficile. This germ can cause severe stomach problems. The study checks if the medicine is safe and works well for these patients. **Key points:** - **Length and Visits:** Participants take the medicine for 14 days and are checked on different days up to 24 weeks. - **Eligibility:** Only adults who have had 3 or more C. difficile infections in the last year can join. - **Risks and Compensation:** People with severe illness or other infections are not eligible, and participants will need to follow specific rules. The study involves taking ibezapolstat pills twice a day with food. Doctors will see if the medicine helps patients feel better and prevents future infections. Participants will be checked for side effects and their health will be monitored over several months. This study aims to help find better treatments for those who suffer from repeated C. difficile infections. If you think you fit the criteria, consider joining to help advance medical knowledge.